The frequency of somatic mutations in EGFR gene in smoking and non-smoking patients with lung adenocarcinoma
- Authors: Badaev E.A1,2, Fazlov V.V3, Kvon T.A4, Gulyaeva L.F5,4
-
Affiliations:
- State Regional Novosibirsk Clinical Tuberculosis Hospital
- Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences
- Novosibirsk Regional Clinical Oncologic
- Novosibirsk State University
- Fedaral Research Center of Fundamental and Translational Medicine
- Issue: Vol 22, No 4 (2019)
- Pages: 35-42
- Section: Articles
- URL: https://journals.eco-vector.com/1560-9596/article/view/112629
- DOI: https://doi.org/10.29296/25877313-2019-04-06%20%20%20%20©%20Коллектив%20авторов,%202019
- ID: 112629
Cite item
Abstract
Keywords
Full Text
About the authors
E. A Badaev
State Regional Novosibirsk Clinical Tuberculosis Hospital; Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences
Email: Eugene3007@gmail.com
Surgeon; Post-graduate Student
V. V Fazlov
Novosibirsk Regional Clinical Oncologic
Email: vadimkozlov80@mail.ru
Ph.D. (Med.), Head of Department
T. A Kvon
Novosibirsk State University
Email: tatyanakwon@yandex.ru
Student, V. Zelman Institute for the Medicine and Psychology
L. F Gulyaeva
Fedaral Research Center of Fundamental and Translational Medicine; Novosibirsk State University
Email: lfgulyaeva@gmail.com
Dr.Sc. (Biol.), Professor, Head of Laboratory; Heads of Department^ V. Zelman Institute for the Medicine and Psychology
References
- Rafiemanesh H., Mehtarpour M., Khani F., Hesami S.M., Shamlou R., Towhidi F., Salehiniya H., Makhsosi B.R., Moini A. Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world // J. Thorac. Dis. 2016; 8:1094-1102.
- Pakzad R., Mohammadian-Hafshejani A., Ghoncheh M., Pakzad I., Salehiniya H. The incidence and mortality of lung cancer and their relationship to development in Asia // Transl. Lung Cancer Res. 2015, 4(6):763-774.
- Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 // Int. J. Cancer. 2010, 127(12):2893-2917.
- Wong M.C.S., Lao X.Q., Ho K.F., Goggins W.B., Tse S. Incidence and mortality of lung cancer: Global trends and association with socioeconomic status // Sci. Rep. 2017, 7(1): 14300.
- Smoking and Tobacco Control Monograph 9. Cigars: Health Effects and Trends. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 1998. NIH publication 98-4302.
- US Department of Health and Human Services Smoking and Health: A National Status Report.Washington, DC: US Department of Health and Human Services; 1987.
- Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers - a different disease // Nat. Rev. Cancer. 2007, 7(10):778-790.
- Zhou F., Zhou C. Lung cancer in never smokers - the East Asian experience // Transl. Lung Cancer Res. 2018, 7(4):450-463.
- Raaschou-Nielsen O., Andersen Z.J., Beelen R., Samoli E., Stafoggia M., Weinmayr G., Hoffmann B., Fischer P., Nieuwenhuijsen M.J., Brunekreef B., Xun W.W., Katsouyanni K., Dimakopoulou K., Sommar J., Forsberg B., Modig L., Oudin A., Oftedal B., Schwarze P.E., Nafstad P., De Faire U., Pedersen N.L., Ostenson C.G., Fratiglioni L., Penell J., Korek M., Pershagen G., Eriksen K.T., Sorensen M., Tjonneland A., Ellermann T., Eeftens M., Peeters P.H., Meliefste K., Wang M., Bueno-de-Mesquita B., Key T.J., de Hoogh K., Concin H., Nagel G., Vilier A., Grioni S., Krogh V., Tsai M.Y., Ricceri F., Sacerdote C., Galassi C., Migliore E., Ranzi A., Cesaroni G., Badaloni C., Forastiere F., Tamayo I., Amiano P., Dorronsoro M., Trichopoulou A., Bamia C., Vineis P., Hoek G. Air pollution and lung cancer incidence in 17 European cohorts: Prospective analyses from the European Study of cohorts for air pollution effects // Lancet Oncol. 2013, 14(9):813-822.
- Mousavi S.M., Schmid S., Germy T., Tfruh M. Lung cancer and smoking trends in the young in Switzerland: a study based on data of the National Institute for Cancer Epidemiology and Registration and of the Swiss Health Surveys // Swiss Med. Wkly. 2018. 148. w14708.
- Arteaga C.L. Epidermal growth factor receptor dependence in human tumors: more than just expression? // Oncologist. 2002, 7(4):31-39.
- Bancroft C.C., Chen Z., Yeh J., Sunwoo J.B., Yeh N.T., Jackson S., Van Waes C. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines // Int. J. Cancer. 2002, 99(4):538-548.
- Shigematsu H., Lin L., Takahashi T., Nomura M., Suzuki M., Wistuba I.I., Fong KM, Lee H., Toyooka S., Shimizu N., Fujisawa T., Feng Z., Roth JA., Herz J., Minna J.D., Gazdar A.F. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers // J. Natl. Cancer Inst. 2005, 97(5):339-346.
- Rekhtman N., PaikP.K., Arcila M.E., Tafe L.J., Oxnard G.R., Moreira A.L., Travis W.D., Zakowski M.F., Kris M.G., Ladanyi M. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: Lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations // Clin. Cancer Res. 2012, 18(4):1167-1176.
- Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers - a different disease // Nat. Rev. Cancer. 2007, 7(10):778-790.
- Maemondo M., Inoue A., Kobayashi K., Sugawara S., Oizumi 5., Isobe H., Gemma A., Harada M., Yoshizawa H., Kinoshita 1., Fujita Y., Okinaga S., Hirano H., Yoshimori K., Harada T., Ogura T., Ando M., Miyazawa H., Tanaka T., Saijo Y., Hagiwara K., Morita S., Nukiwa T. North-East Japan Study Group. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR // N. Engl. J. Med. 2010, 362(25):2380-2388
- Helena C., Rostislav V. Afatinib in the Treatment of Advanced Non-Small Cell Lung Cancer with Rare EGFR (in exon 18-T179X) Mutation - a Case Report // Klin. Onkol. 2018, 31(5):380-383
- Bollinger M.K., Agnew A.S. Mascara G.P. Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation // J. Oncol. Pharm. Pract. 2018, 24(5):379-388
- Olak J., Colson Y. Gender differences in lung cancer: have we really come a long way, baby? // J. Thorac. Cardiovasc. Surg. 2004, 128(3): 346-351
- Couraud S., Zalcman G., Milleron B., Morin F., Souquet P.J. Lung cancer in never smokers - a review // Eur. J. Cancer. 2012, 48(9): 1299-1311
- Chapman A.M., Sun K.Y., Ruestow P., Cowan D.M., Madl A.K. Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers // Lung Cancer. 2016, 102:122-134